【摘 要】
:
Colorectal cancer(CRC)is the third most frequently diagnosed cancer worldwide,responsible for over 880 000 deaths each year.Growth/differentiation factor 15(GDF
【机 构】
:
Department of Medical and Molecular Biology,Faculty of Medical Sciences in Zabrze,Medical University
论文部分内容阅读
Colorectal cancer(CRC)is the third most frequently diagnosed cancer worldwide,responsible for over 880 000 deaths each year.Growth/differentiation factor 15(GDF-15)is reported to be a promising diagnostic and prognostic factor in CRC.It induces pleiotropic effects in tumor cells:proliferation,stemness,invasion and metastasis.Some studies indicate that GDF-15 may stimulate angiogenesis in malignant neoplasms.However,it has not been investigated in CRC yet.The aim of our study was to determine the level of GDF-15 and the concentrations of hypoxia-inducible factor-1α(HIF-1α),VEGF-A and chemokine-like receptor 1(CMKLR1)in tumor and margin specimens of CRC in relation to histological grade and TNM staging.The study comprised 33 samples of tumor and margin tissues obtained from CRC patients.To assess the concentration of GDF-15,HIF-1α,VEGF-A and CMKLR1,commercially available enzyme-linked immunosorbent assay(ELISA)kits were used.We found significantly increased levels of GDF-15 and CMKLR1 in tumor tissue compared to margin tissue and higher concentrations of HIF-1α and VEGF-A in margin tissue than in tumor tissue.The levels of GDF-15 and HIF-1α were significantly correlated with VEGF-A and CMKLR1 in margin tissue.In CRC,the increased level of GDF-15 might stimulate angiogenesis through upregulation of HIF-1α,VEGF A and CMKLR1 expression.Our study is the first one to reveal the correlation between the levels of GDF-15 and CMKLR1 in CRC.The elevated levels of HIF-1α and VEGF-A in tumor-free margin tissues suggest that noncancer cells in the tumor microenvironment are an important source of proangiogenic factors.
其他文献
Pregnancy-induced hypertension(PIH),including gestational hypertension and preeclampsia,accounts for the majority of maternal and perinatal morbidity and mortality.Strontium(Sr)has been recently associated with preeclampsia in a small group of women;howev
目前各国采取有力措施抗击新冠疫情,同时新冠疫苗成功上市并在人群中大规模接种,伴随着疫情点式小规模散发,全球将逐渐走向后疫情时代.本文介绍了新冠疫苗的研发尤其是疫苗研
替格瑞洛是一种新型的P2Y12受体拮抗剂,属于环戊三唑嘧啶类化合物,替格瑞洛与其他药物相比具有更快、更强的抑制血小板效果,已经被多部指南推荐为急性冠脉综合征患者的首选抗血小板药物或一线用药,无论是否接受早期再灌注治疗的急性冠脉综合征患者尽早和充分使用替格瑞洛都可改善患者的预后,目前广泛应用于急性ST段抬高型心肌梗死患者、非ST段抬高型急性冠脉综合征患者、不稳定性心绞痛患者等的抗血小板治疗。本文对替格瑞洛用于急性冠脉综合征的临床研究和安全性做一综述,为临床用药提供参考。
目的:对2型糖尿病合并肥胖患者采用利拉鲁肽联合胰岛素治疗的效果进行探究.方法:选择我院收治的2型糖尿病合并肥胖患者102例作为纳入对象,选取时间为2018年2月到2020年1月.按
The abnormal growth of epithelium-like cells has been noticed in spontaneously hypertensive rats(SHRs)with hypertensive nephropathy.However,the characteristics of abnormal epithelium-like cells and their pathogenesis in hypertensive nephropathy are not fu
目的:探讨米氮平及草酸艾司西酞普兰治疗抑郁症患者的临床效果。方法:选择2019年4月—2020年4月本院收治的64例抑郁症患者,依据随机数字表法分成两组各32例。对照组给予草酸艾司西酞普兰片口服治疗,初始剂量为10 mg/次,1次/d,根据患者个体反应,加大剂量为20 mg/次,1次/d,于晚上服用;观察组在此基础上加用米氮平片治疗,初始剂量为15 mg/次,1次/d,用药7 d后根据患者病情,加大剂量为30 mg/次,1次/d。两组需连续用药60 d。比较两组临床疗效、匹兹堡睡眠质量指数评分(PSQI)
目的:观察胰岛素与西格列汀联合用药方案治疗老年2型糖尿病的有效性和安全性。方法:以本院2019年2月—2020年2月收治的82例老年2型糖尿病患者为本次研究对象,按照双色球随机分组法将患者分为对照组和实验组各41例。对照组于早中晚餐前分别给予谷赖胰岛素10、10和8 U皮下注射;实验组在对照组基础上联用西格列汀,100 mg/次口服,1次/d。两组患者均持续给药3个月为1个疗程,连续治疗3个疗程。比较两组患者血脂指标、血糖指标、总有效率和不良反应情况。结果:治疗前,两组患者甘油三酯(TG)、总胆固醇(TC
目的:探讨本院Ⅰ类切口手术预防使用抗菌药物的干预效果。方法:选择本院2014年出院的Ⅰ类切口手术病历1200例作为对照组,2015—2019年出院的Ⅰ类切口手术病历各1200例分别作为干预组1、干预组2、干预组3、干预组4和干预组5,通过建立Ⅰ类切口手术围手术期预防使用抗菌药物的点评标准,从用药指征、药品选择、给药时机、术中用药、用法用量、用药疗程、联合用药、预防用药更换等方面进行点评。结果:通过一系列干预,本院Ⅰ类切口手术预防性使用抗菌药物率由干预前的32.17%下降至25.75%;24 h内停药率由干
本文对生药学线上教学、线下教学,如何量化生药学考核指标,优化过程性评价和终结性评价进行了探讨;同时利用自主学习,教师指导学生查阅文献,激发了学生的学习热情,夯实了学生的基础知识,培养了学生的自学能力,提升了学生终身学习的习惯。在教学中,融入爱国主义教育,对未来培养爱岗敬业、应用型、创新型、复合型药学类人才具有积极的意义。
目的:探讨乌灵胶囊联合曲唑酮治疗苯二氮䓬类药物(BZDs)依赖性睡眠障碍患者效果及对5羟色胺(5-HT)和神经元特异性烯醇化酶(NSE)表达。方法:选择本院2018年1月—2021年1月收治的BZDs依赖性睡眠障碍患者200例,运用随机表法分为两组,各100例患者。对照组服用盐酸曲唑酮片,开始剂量50 mg/次,2次/d,服用2周后按照患者病情增至150~200 mg/次,2次/d;研究组在曲唑酮基础上口服乌灵胶囊,3粒/次,3次/d。两组患者治疗周期均为4周。比较两组患者治疗4周总有效率;治疗前与治疗4